سعر Meloxicam 15 mg tablets (Amriya) 2023

Generic meloxicam 15 mg oral tablets, 10 tablets (1 strip) by Amriya Pharmaceutical Industries, Egypt; oxicam NSAID listed for arthritis and rheumatic conditions.

• Relief of the signs and symptoms of osteoarthritis.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Relief of the signs and symptoms of rheumatoid arthritis.Population: AdultsDailyMed (U.S. National Library of Medicine)
• Relief of the signs and symptoms of pauciarticular or polyarticular course juvenile rheumatoid arthritis in patients weighing 60 kg or more.Population: Children weighing 60 kg or moreDailyMed (U.S. National Library of Medicine)

• Most common adverse reactions in adults (2% or more and higher than placebo) include diarrhoea, dyspepsia, nausea, abdominal pain, oedema, influenza-like symptoms, headache and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Known hypersensitivity to meloxicam or any component.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• History of asthma, urticaria or other allergic-type reactions after aspirin or other NSAIDs.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• In the setting of coronary artery bypass graft (CABG) surgery.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: NSAIDs increase the risk of serious cardiovascular thrombotic events (myocardial infarction, stroke), which may occur early in treatment and increase with duration, and of serious gastrointestinal bleeding, ulceration and perforation, which can be fatal; elderly patients and those with prior ulcer disease or GI bleeding are at greater risk.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Other warnings include hepatotoxicity, new or worsening hypertension, heart failure and oedema, renal toxicity and hyperkalaemia, anaphylactic reactions, serious skin reactions (including DRESS), fetal toxicity and haematological toxicity.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Anticoagulants (e.g., warfarin), antiplatelets (e.g., aspirin), SSRIs/SNRIsIncreased risk of bleeding; monitor for signs of bleeding.DailyMed (U.S. National Library of Medicine)
• ACE inhibitors, angiotensin receptor blockers, beta-blockers, diureticsNSAIDs may reduce their antihypertensive/diuretic effect and increase the risk of renal impairment, especially in elderly or volume-depleted patients.DailyMed (U.S. National Library of Medicine)
• Lithium, methotrexate, cyclosporineNSAIDs may increase their concentrations or toxicity; monitor.DailyMed (U.S. National Library of Medicine)

• Use of NSAIDs at about 30 weeks of gestation and later can cause premature closure of the fetal ductus arteriosus; use at about 20 weeks or later can cause fetal renal dysfunction leading to oligohydramnios. Avoid use from about 30 weeks; if needed between 20 and 30 weeks, use the lowest dose for the shortest duration.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• There are no human data on meloxicam in breast milk; consider the developmental and health benefits of breastfeeding together with the mother's clinical need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Meloxicam: Oxicam NSAID with anti-inflammatory, analgesic and antipyretic properties; inhibits prostaglandin biosynthesis.